Novel Energy Metabolic Signaling Molecule With Therapeutic Potential

NCT04713319 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Panavital
OTHER: Placebo

Sponsor

Petteri Hirvonen

Collaborators

[object Object]